Our company has provided products without charge to academic research institutes that use the self-assembling peptide for study purposes.
For Companies
- Partner
- For Companies
Research of novel medical technologies using the self-assembling peptide, our core technology, has been progressing in multiple fields. PuraMatrix™, the first-generation self-assembling peptide, has the excellent ability to regenerate tissues with high affinity for cells. Moreover, PuraMatrix™ has been nanostructured with high biodegradability and biocompatibility; therefore, it has gained a high reputation as a drug delivery system (DDS).
| Field | Examples of Research Results |
|---|---|
Regenerative Medicine |
Bone, myocardium, blood vessels, etc. |
Cell Therapy |
ES cells, mesenchymal stem cells, liver cells, neurons, osteoblasts, chondrocytes, vascular endothelial cells, etc. |
Surgical Treatment |
Wound healing, etc. |
Drug Discovery Technology |
Use as a drug delivery system (DDS) for proteins and peptides (BMP, PDGF, IGF-1, etc.) |
Research Reagents |
An exclusive distribution agreement with BD Biosciences (contract concluded) |
